Trial · NCT00000170

Occlusion Versus Pharmacologic Therapy for Moderate Amblyopia

NCT00000170, Phase 3, Completed, Jaeb Center for Health Research

3 sourcestrials-2026-11-12-0.5.0

Cite this record

ConductScience Library. Occlusion Versus Pharmacologic Therapy for Moderate Amblyopia. Trials, record NCT00000170. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT00000170

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title: Occlusion Versus Pharmacologic Therapy for Moderate Amblyopia
NCT number: NCT00000170
Status: Completed
Phases: Phase 3
Enrollment: 419 participants, actual
Lead sponsor: Jaeb Center for Health Research
Conditions: Amblyopia
Interventions: Atropine, Eye Patch
First posted: 1999-09-24
Last updated: 2014-03-06

Source ClinicalTrials.gov

Registered outcomes4

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

List	Outcome	Time frame
Primary	Visual acuity in the amblyopic eye	6 months
Secondary	Visual acuity in the amblyopic eye	24 months
Secondary	Extended Follow-up: (Primary) To determine the long-term visual acuity outcome at age 10 years and at age 15 years in patients diagnosed with amblyopia before age 7 years	age 10 years and age 15 years
Secondary	Extended Follow-up: To determine whether the long-term visual acuity outcome at age 10 yrs and age 15 yrs differs between patients who received patching followed by best clinical care and patients who received atropine followed by best clinical care	age 10 years and age 15 years

Source ClinicalTrials.gov

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers16

The papers the trial lists on ClinicalTrials.gov.

PMID	Listed as	Source
11507585	BACKGROUND	PubMed
11545641	BACKGROUND	PubMed
11879129	BACKGROUND	PubMed
11879130	BACKGROUND	PubMed
12917184	BACKGROUND	PubMed
14516801	BACKGROUND	PubMed
14516802	BACKGROUND	PubMed
14609923	BACKGROUND	PubMed
15710809	BACKGROUND	PubMed
16414520	BACKGROUND	PubMed

1 to 10 of 16

See all 16 papers

Grants1

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

Project	Title	Principal investigators	Organization	Funder	Fiscal years
U10EY011751	Pediatric Eye Disease Investigator Group Coordinating Center	KRAKER, RAYMOND	JAEB CENTER FOR HEALTH RESEARCH, INC.	NATIONAL EYE INSTITUTE	1997 to 2018

Source NIH RePORTER

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov: 2026-11-12; ClinicalTrials.gov
Results, from AACT: 2026-03-23; AACT
NIH grant links: 2026-11-13; NIH RePORTER

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT00000170

GET https://conductscience.org/api/trials/v1/NCT00000170/registered

API reference For AI assistants